Watermark
  Back to Search Results

BGB-A317-fruquintinib-201

Completed

Efficacy and Safety of Tislelizumab in Combination With Fruquintinib in Participants With Selected Solid Tumors

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-A317-fruquintinib-201

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT04716634

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20211070

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan